By Abigail Townsend
Date: Tuesday 23 Mar 2021
(Sharecast News) - A cocktail of antibodies developed by Roche and Regeneron Pharmaceuticals to treat Covid-19 has been shown to cut hospitalisation or death by 70%, the Swiss drugmaker said on Tuesday.
By Alexander Bueso
Date: Tuesday 26 Jan 2021
(Sharecast News) - Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.
By Alexander Bueso
Date: Wednesday 30 Sep 2020
(Sharecast News) - Early trial results for Regeneron's monoclonal antibody cocktail showed that it helped to alleviate symptoms in patients in mild-to-moderate cases of Covid-19.
Currency | US Dollars |
Share Price | $ 490.28 |
Change Today | $ -115.11 |
% Change | -19.01 % |
52 Week High | $1,201.76 |
52 Week Low | $485.00 |
Volume | 6,313,059 |
Shares Issued | 107.80m |
Market Cap | $52,852m |
RiskGrade | 129 |
Strong Buy | 10 |
Buy | 10 |
Neutral | 5 |
Sell | 1 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
16:00 | 1,330 @ $489.52 |
15:59 | 100 @ $490.11 |
15:59 | 400 @ $490.10 |
15:59 | 540 @ $490.10 |
15:59 | 118 @ $489.95 |
You are here: research